Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Reexamination Certificate
2006-12-12
2006-12-12
Jones, Dameron L. (Department: 1618)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
C424S001690, C534S015000
Reexamination Certificate
active
07147837
ABSTRACT:
The present invention relates to improved diagnostic agents for Magnetic Resonance Imaging and optical imaging. In particular, this invention relates to MRI and optical imaging agents that allow for the sensitive detection of a specific bioactivity within a tissue. These agents are prodrug contrast agents which are bioactivated in vivo in the presence of the specific bioactivity. This invention also relates to pharmaceutical compositions comprising these agents and to methods of using the agents and compositions comprising the agents.
REFERENCES:
patent: 4880008 (1989-11-01), Lauffer
patent: 4899755 (1990-02-01), Lauffer et al.
patent: 5094848 (1992-03-01), Brixner
patent: 5171563 (1992-12-01), Abrams et al.
patent: H1312 (1994-05-01), Coughlin et al.
patent: RE35524 (1997-06-01), Saulnier et al.
patent: 5707605 (1998-01-01), Meade et al.
patent: 5783662 (1998-07-01), Janmey et al.
patent: 5932188 (1999-08-01), Snow et al.
patent: 19507822 (1996-08-01), None
patent: 264333 (1998-04-01), None
patent: WO 91/03200 (1991-03-01), None
patent: WO 95/15306 (1995-06-01), None
patent: WO 95/15319 (1995-06-01), None
patent: WO 96/23526 (1996-08-01), None
patent: WO 96/38184 (1996-12-01), None
Allen et al., “Liposomes containing synthetic lipid derivatives of poly (ethylene glycol) show prolonged circulation half-lives in vivo,”Biochim. Biophys. Acta, 1991, 1066:29-36.
Blau, “Radiotracers for Functional Brain Imaging,”Seminars in Nuclear Medicine, vol. XV, No. 4 (Oct. 1985).
Brechbiel et al., “Synthesis of 1-(p-Isothiocyanatobenzyl) Derivatives of DTPA and EDTA. Antibody Labeling and Tumor-Imaging Studies,”Inorg. Chem., 1986, 25:2772-2781.
Cacheris et al., “The Relationship between Thermodynamics and the Toxicity of Gadolinium Complexes,”Mag. Res. Imag., 1990, 8:467-481.
Carter and Ho, “Structure of Serum Albumin,”Adv. Protein Chem., 1994, 45:153-203.
Chan et al., “In vitro studies on the Hypoxic Retention of a Novel Technetium—99m Labeled Nitroimidazole in Rat Heart,”J. Nuclear Med., 1994, 35:18P, Abstract No. 65.
Chu, “The Quantitative Analysis of Structure-Activity Relationships,”Burger's Medicinal Chemistry, Part 1, 1980, 4thed., pp. 393-418.
Cox et al., “Synthesis of C- and N- Functionalised Derivatives of 1,4,7—Triazacyclonon-ane-1,4,7-triyltriacetic acid (NOTA), 1,4,7,10—Tetra-azacycoldodecane-1,4,7,10—tetrayltetra-acetic Acid (DOTA), and Diethylenenetriaminepenta-acetic Acid (DTPA): Bifunctional Complexing Agents for the Derivatisation of Antibodies,”J. Chem. Soc. Perkin Transactions I, 1990, pp. 2567-2576.
Green et al., “Protection for the Hydroxyl Group, including 1,2- and 1,3-Diols,”Protective Groups in Organic Synthesis, 1981 2nded., J. Wiley & Sons, pp. 10-86.
Harris et al., “Ferric Ion Sequestering Agents. 6. The Spectrophotometric and Potentiometric Evaluation of Sulfonated Tricatecholate Ligands,”J. Am. Chem. Soc., 1981, 103:2667.
Harris et al., “Spectrophotometric Determination of the Proton-Dependent Stability Constant of Ferric Enterobactin,”J. Am. Chem. Soc., 1979, 101:2213.
He and Carter, “Atomic Structure and Chemistry of Human Serum Albumin,”Nature, 1992, 358:209-215.
Hoey and Smith, “Chemistry of X-Ray Contrast Media,”Radiocontrast Agents, 1984, Springer-Verlag, NY, Chapter 1, pp. 23-125.
Horrocks and Albin, “Lanthanide Ion Luminescence in Coordination Chemistry and Biochemistry,”Progr. Inorg. Chem., 1984, 31:1-104.
Kragh-Hansen, “Molecular Aspects of Ligand Binding to Serum Albumin,”Pharm. Rev., 1981, 33:17-53.
Kumar et al., “Equilibrium and Kinetic Studies of Lanthanide Complexes of Marcrocyclic Polyamino Carboxylates,”Inorg. Chem., 1993, 32:587-593.
Lauffer, “Paramagnetic Metal Complexes as Water Proton Relaxation Agents for NMR Imaging: Theory and Design,”Chemical Reviews, 1987, 87:901-927.
Leo, “Partition Coefficients and their Uses,”Chemical Reviews, 1971, 71:525-616.
March,Advanced Organic Chemistry: Reactions, Mechanisms, and Structure, 1992, 4thed., J. Wiley & Sons, pp. 392-396.
McMurry et al., “Convenient Synthesis of Bifunctional Tetraaza Macrocycles,”Bioconjugate Chemistry, 1992, 3:108-117.
Okezaki et al., “Structure-Tissue Distribution Relationship Based on Physiological Pharmacokinetics for NY-198, A New Antimicrobial Agent, and the Related Pyridonecarboxylic Acids,”Drug Metabolism and Disposition, 1988, 16:865-874.
Paphadjopoulos et al., “Sterically Stabilized Liposomes: Improvements in Pharmacokinetics and Antitumor Therapeutic Efficacy,”Proc. Natl. Acad. Sci. USA, 1991, 88:11460-11464.
Roda et al., “Quantitative Aspects of the Interaction of Bile Acids with Human Serum Albumin,”J. Lipid Research, 1982, 23:490-495.
Rolinson and Sutherland, “The Binding of Antibiotics to Serum Proteins,”British J. Pharmacol., 1965, 25:638-650.
Schumhmann-Giampieri et al., “Preclinical Evaluation of Gd-EOB-DTPA as a Contrast Agent in MR Imaging of the Hepatobiliary System,”Radiology, 1992, 183:59-64.
Tinoco et al., “Equilibrium Dialysis and Scatchard Plots,”Physical Chemistry: Principles and Applications in Biological Sciences, 1985, 2nded., Prentice-Hall, pp. 172-177.
Villringer et al., “Dynamic Imaging with Lanthanide Chelates in Normal Brain: Contrast Due to Magnetic Susceptibility Effects,”Mag. Res. Med., 1988, 6:164-174.
Watson et al., “Contrast Agents in Magnetic Resonance,”Magnetic Resonance Imaging, 1992, 2nded., Mosby-Year Book, Inc., vol. 1, Chapter 14.
Williams and Rappaport, Synthesis of Enantiomerically Pure Diethylenetriaminepentaacetic Acid Analogues. L-Phenylalanine as the Educt for Substitution at the Central Acetic Acid,'J. Org. Chem., 1993, 58:1151-1158.
Wright et al., “Heats and Entropies of Formation of Metal Chelates of Polyamine and Polyaminocarboxylate Ligands,”Anal. Chem., 1965, 37:884-892.
Dumas Stephane
Dunham Stephen O.
Lauffer Randall B.
McMurry Thomas J.
Parmelee David J.
Epix Pharmaceuticals Inc.
Fish & Richardson P.C.
Jones Dameron L.
LandOfFree
Bioactivated diagnostic imaging constrast agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bioactivated diagnostic imaging constrast agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bioactivated diagnostic imaging constrast agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3687240